share_log

HC Wainwright & Co. Reiterates Buy on Biora Therapeutics, Maintains $50 Price Target

HC Wainwright & Co. Reiterates Buy on Biora Therapeutics, Maintains $50 Price Target

HC Wainwright & Co.重申買入Biora Therapeutics,維持50美元的目標股價
Benzinga ·  01/02 12:11

HC Wainwright & Co. analyst Joseph Pantginis reiterates Biora Therapeutics (NASDAQ:BIOR) with a Buy and maintains $50 price target.

HC Wainwright & Co. 分析師約瑟夫·潘吉尼斯重申了Biora Therapeutics(納斯達克股票代碼:BIOR)的買入並維持50美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論